Device user fee renewal bill passes crucial subcommittee; Covidien launches new hypertension treatment;

 @FierceMedDev: Baxter is facing an SEC subpoena for records of its 2010 pump recall. More | Follow @FierceMedDev

> A health subcommittee of the U.S. House of Representatives has signed off on a bill that would renew the FDA's user fee program for medical device and drug companies. Story

> The FDA has approved St. Jude's ($STJ) Assura line of implantable defibrillators, which are designed to reduce the amount of inappropriate shocks. More

> Covidien ($COV) is set to unveil OneShot, its new treatment for drug-resistant hypertension, at the EuroPCR conference in Paris on May 16. Story

> Devicemaker Aethelon Medical is touting positive results from a 90-day test of its hepatitis C-treating Hemopurifier, as all patients treated with the device were left with no detectable traces of the virus. Release

> Guided Therapeutics thinks its LuViva cervical scanner can be combined with HPV testing to optimize early detection of cervical cancer, and a new study estimates that the device could help reduce overtreatment of false positives by 33%. News

> The Corporate Whistle Blower Center is launching an initiative to investigate the U.S. Medical Device industry for alleged corruption regarding the sale of defective surgical implants. Release

Pharma News

 @FiercePharma: Response to Cipla's cancer-drug price cuts in India has execs mulling more—Reuters | Follow @FiercePharma

> Novartis may weigh Lucentis price cut in U.K. News

> Abbott to pay $1.6B to wrap up Depakote marketing probe. More

> Docs riled by FDA's proposal to open up drug access. Article

> Sanofi plant starts shutdown with 112 layoffs. Spotlight

Biotech News

 @FierceBiotech: Honeybee substance freezes prostate cancer growth (Hint: it's not honey) More | Follow @FierceBiotech

 @RyanMFierce: Talon takes it in the teeth, back to penny stock, after FDA says more time needed 2 review lead cancer drug. Bloomberg | Follow @RyanMFierce

> Talon sinks after FDA prolongs cancer drug review. Article

> Amgen, VC groups pump $16.5M into Sutro Biopharma. News

> Eleven adds $20M in venture cash as it preps for the clinic. More

> Arena shares up after FDA briefing on lorcaserin. Story

Medical Devices News

 @FierceMedDev: Baxter is facing an SEC subpoena for records of its 2010 pump recall. More | Follow @FierceMedDev

> Boston Scientific's CEO: CRM business in active rebuilding mode. Article

> Canada's Monteris snags $9M in investments for NeuroBlate. News

> Dutch test boosts prospects for photoacoustic breast imaging device. Story

> Allergan subpoenaed over Lap-Band obesity device. More

Pharma Manufacturing News

> Baxter bitten again by problems with Colleague infusion pumps. News

> Pfizer to grow manufacturing capacity in Indonesia. Article

> Sanofi closing plant in Missouri, 4 years later than expected. More

> BASF erecting 50,000-ton-plus formic acid plant in Louisiana. Story

Biotech Research News

> Researchers find key to premature aging syndrome. Spotlight

> Controversial bird flu study details revealed. Article

> Stem cells grown from skin treat muscular dystrophy in mice. News

> Stem cell/gene therapy holds HIV at bay in mouse trials. More

And Finally ... The law firm Bernstein Liebhard LLP wants to know whether corporate pressure cited by a survey of FDA workers had any impact on the approval process for vaginal surgical mesh and metal hip implants. The 2011 survey by the Union of Concerned Scientists, released earlier this year, revealed some regulators expressed concern about "the influence of special interests on device approval decisions." Release